🇺🇸 dexamedetomidine in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Burkholderia Test Positive — 2 reports (16.67%)
  2. Recalled Product — 2 reports (16.67%)
  3. Acinetobacter Test Positive — 1 report (8.33%)
  4. Acute Respiratory Failure — 1 report (8.33%)
  5. Atrial Fibrillation — 1 report (8.33%)
  6. Atrioventricular Block First Degree — 1 report (8.33%)
  7. Bacteraemia — 1 report (8.33%)
  8. Blood Creatine Phosphokinase Increased — 1 report (8.33%)
  9. Blood Culture Positive — 1 report (8.33%)
  10. Blood Pressure Decreased — 1 report (8.33%)

Source database →

Other Other approved in United States

Frequently asked questions

Is dexamedetomidine approved in United States?

dexamedetomidine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for dexamedetomidine in United States?

Assiut University is the originator. The local marketing authorisation holder may differ — check the official source linked above.